|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$2.33 |
$2.50 |
$2.28 |
$2.43 |
13.10K | 04/23/2024 |
$2.41 |
$2.51 |
$2.36 |
$2.51 |
13.00K | 04/24/2024 |
$2.51 |
$2.58 |
$2.44 |
$2.44 |
9.10K | 04/25/2024 |
$2.49 |
$2.61 |
$2.22 |
$2.30 |
27.80K | 04/26/2024 |
$2.44 |
$2.45 |
$2.36 |
$2.42 |
3.40K |
|
CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world.. In China, Co.'s first commercial product, EVOMELA® is approved for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The other core hematology/oncology assets in our pipeline include: CNCT19, which is being developed as a potential treatment for patients with hematological malignancies which express CD19 including, B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma. | |
|
CASI Pharmaceuticals (CASI) has the following price history information. Looking back at CASI historical stock prices for the last five trading days, on April 22, 2024, CASI opened at $2.33, traded as high as $2.50 and as low as $2.28, and closed at $2.43. Trading volume was a total of 13.10K shares. On April 23, 2024, CASI opened at $2.41, traded as high as $2.51 and as low as $2.36, and closed at $2.51. Trading volume was a total of 13.00K shares. On April 24, 2024, CASI opened at $2.51, traded as high as $2.58 and as low as $2.44, and closed at $2.44. Trading volume was a total of 9.10K shares. On April 25, 2024, CASI opened at $2.49, traded as high as $2.61 and as low as $2.22, and closed at $2.30. Trading volume was a total of 27.80K shares. On April 26, 2024, CASI opened at $2.44, traded as high as $2.45 and as low as $2.36, and closed at $2.42. Trading volume was a total of 3.40K shares.
CASI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CASI Pharmaceuticals shares, starting with a $10,000 purchase of CASI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$18.50 |
|
End price/share: |
$2.42 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-86.92% |
|
Average Annual Total Return: |
-18.40% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,308.89 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $2.43 | 04/23/2024 | $2.51 | 04/24/2024 | $2.44 | 04/25/2024 | $2.30 | 04/26/2024 | $2.42 |
|
|